| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sangamo Therapeutics, Inc (SGMO) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $331.6K | - | |
| Other | 696.7K | $121.9K | - | |
| VP | 647.4K | $113.3K | - | |
| VP | 328.7K | $57.5K | - | |
| Other | 235.3K | $41.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $17.29 | $432,305.00 | -9.6% | |
| Mar 10, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $16.68 | $200,201.20 | -2.8% | |
| Mar 5, 2015 | Mento Steven J | Director | Sale+OE | 6,501 | $18.30 | $118,939.05 | -34.6% | |
| Mar 5, 2015 | Ando Dale G | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $18.29 | $274,282.50 | -13.6% | |
| Mar 4, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 10,000 | $18.00 | $180,000.00 | -4.6% | |
| Mar 3, 2015 | Ringo William R | Director | Sale+OE | 2,200 | $17.21 | $37,862.00 | -73.3% | |
| Mar 2, 2015 | Gregory Philip D | SVP Of Research &CSO | Sale+OE | 15,000 | $17.26 | $258,937.50 | -11.4% | |
| Feb 17, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $15.69 | $392,150.00 | -9.6% | |
| Feb 12, 2015 | Ramasastry Saira54 | Director | Sale+OE | 10,000 | $15.00 | $150,000.00 | -100% | |
| Feb 10, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $12.65 | $151,750.49 | -1.9% |